| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| AbbVie is actively enhancing its operations through digital transformation initiatives, reflecting a strong commitment to innovation. Product performance, particularly with drugs like Skyrizi and Rinvoq, is robust and positively influences market outlook. This combination of strong product offerings and modern technology integration positions the company favorably in the competitive landscape. However, external regulatory pressures and market competition remain potential challenges. |
| The price action of ABBVIE INC (ABBV) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.3 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for ABBV since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.5, and the negative at -0.2 on 2024-11-26. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (2.8) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| ABBV | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-26 | 0%(0%) | 0 | 0% | 0.3 | 2.8 | -1 | |||||||
| 2024-11-19 | 0%(0%) | 0 | 0% | 0.3 | 2.9 | -1 | |||||||
| 2024-11-05 | 0%(0%) | 0 | 0% | 0.3 | 2.6 | -1 | |||||||
| 2024-11-04 | 0%(0%) | 0 | 0% | 0.3 | 2.6 | -1 | |||||||
| 2024-10-31 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| 2024-10-30 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| 2024-10-29 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| 2024-10-22 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| 2024-10-17 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| 2024-10-03 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-06-11 22:52:26 The investor outlook towards companies in the pharmaceutical sector reflects on the leadership and strategic decisions affecting their stock performance. |
| 2025-06-11 22:52:26 The disparity in participation of drug-selling companies in the broader market rally signals competition challenges within the sector. |
| 2025-06-11 22:52:26 The underperformance of pharmaceutical stocks compared to the S&P 500 indicates a significant trend within the industry that may affect investor strategies. |
| 2025-06-11 22:52:26 The focus on passive income through dividend stocks emphasizes the importance of company performance in delivering consistent earnings. |
| 2025-06-11 22:52:26 The appeal of investing in high-yield dividend stocks, particularly in the pharmaceutical industry, highlights a growing trend for investors seeking passive income. |